Related references
Note: Only part of the references are listed.Identifying ways to improve diabetes management during cancer treatments (INDICATE): protocol for a qualitative interview study with patients and clinicians
Laura Ashley et al.
BMJ OPEN (2022)
The Impact of Comorbid Diabetes Type 2 on Quality of Life in Cancer Patients Undergoing Chemotherapy
Maria Lavdaniti et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2021)
Diabetes care management patterns before and after a cancer diagnosis: A SEER-Medicare matched cohort study
Laura C. Pinheiro et al.
CANCER (2020)
Diabetes Technology: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
Comparison of the FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System and Point-of-Care Capillary Glucose Testing in Hospitalized Patients With Type 2 Diabetes Treated With Basal-Bolus Insulin Regimen
Rodolfo J. Galindo et al.
DIABETES CARE (2020)
Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial
Eri Wada et al.
BMJ OPEN DIABETES RESEARCH & CARE (2020)
Novel cancer therapies and their association with diabetes
Afreen Idris Shariff et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2019)
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al.
DIABETES CARE (2019)
Preventable Diabetic Complications After a Cancer Diagnosis in Patients With Diabetes: A Population-Based Cohort Study
Erin Worndl et al.
JNCI CANCER SPECTRUM (2018)
The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes
Alexandra K. Lee et al.
DIABETES CARE (2018)
Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial
Thomas Haak et al.
DIABETES THERAPY (2017)
Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial
Thomas Haak et al.
DIABETES THERAPY (2017)
Role of continuous glucose monitoring for type 2 in diabetes management and research
Robert Vigersky et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease
Jing Li et al.
BMC CANCER (2017)
Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes
Marjolein M. J. Zanders et al.
DIABETOLOGIA (2015)
Predictors of Diabetes Self-Management in Older Adults Receiving Chemotherapy
Denise Soltow Hershey et al.
CANCER NURSING (2014)
Share Paper
